Dopamine transporter mutants with cocaine resistance and normal dopamine uptake provide targets for cocaine antagonism

Molecular Pharmacology

Volumn 61, Issue 4, 2002, Pages 885-891

  Lin, Zhicheng ^a   Uhl, George R ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DOPAMINE; DOPAMINE TRANSPORTER; MAZINDOL;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL STRAIN COS1; COCAINE DEPENDENCE; CONTROLLED STUDY; DOPAMINE UPTAKE; DRUG INHIBITION; ENZYME SPECIFICITY; GENE MUTATION; GENETIC TRANSFECTION; MOLECULAR MODEL; MOLECULAR RECOGNITION; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REWARD; STEREOSPECIFICITY;

AMINO ACID SUBSTITUTION; ANIMALS; BINDING, COMPETITIVE; CERCOPITHECUS AETHIOPS; COCAINE; COS CELLS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; DRUG INTERACTIONS; DRUG RESISTANCE; MAZINDOL; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MOLECULAR MOTOR PROTEINS; MUTATION; NERVE TISSUE PROTEINS; TRANSFECTION; TRITIUM;

EID: 0036211072     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.61.4.885     Document Type: Article

References (30)

1. Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium
2. Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants
3. Cocaine receptor: Biochemical characterization and structure-activity relationships of cocaine analogues at the dopamine transporter
4. Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β- (4′-methylphenyl)nortropane as a selective and potent inhibitor of the neuronal dopamine transporter
5. Permeation and gating residues in serotonin transporter
6. The third transmembrane domain of the serotonin transporter contains residues associated with substrate and cocaine binding
7. The role of conserved tryptophan and acidic residues in the human dopamine transporter as characterized by site-directed mutagenesis
8. Dopamine transporter immunoreactivity in rat brain
9. Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters
10. Novel conformationally constrained tropane analogues by 6-endo-trig radical cyclization and stille coupling - Switch of activity toward the serotonin and/or norepinephrine transporter
11. Dopamine transporter transmembrane domain polar mutants AG and AAG values implicate regions important for transporter functions
12. Synthesis and pharmacology of site-specific cocaine abuse treatment agents: 2-substituted-6-amino-5-phenylbicyclo[2.2.2]octanes
13. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding
14. Importance of valine at position 152 for the substrate transport and 2-β-carbomethoxy-3β-(4-fluorophenyl) tropane binding of dopamine transporter
15. (-)-3β-Substituted ecgonine methyl esters as inhibitors for cocaine binding and dopamine uptake
16. Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression
17. Dopamine transporter: Transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition
18. Dopamine transporter tryptophan mutants highlight candidate dopamine- and cocaine-selective domains
19. Tyrosine-533 of rat dopamine transporter: Involvement in interactions with 1-methyl-4-phenylpyridinium and cocaine
20. Critical amino acid residues in transmembrane span 7 of the serotonin transporter identified by random mutagenesis
21. Methods for studying receptors with cultured cells of nervous tissue origin
22. Dopamine fluctuations in the nucleus accumbens during maintenance, extinction, and reinstatement of intravenous D-amphetamine self-administration
23. Is the short-latency dopamine response too short to signal reward error?
24. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA
25. Use of identical assay conditions for cocaine analog binding and dopamine uptake to identify potential cocaine antagonists
26. Dopaminergic agents for the treatment of cocaine abuse
27. Dopamine transporter mutants, small molecules, and approaches to cocaine antagonist/dopamine transporter disinhibitor development
28. 11C] WIN35,428 PET scans
29. Discovery of a novel dopamine transporter inhibitor, 4-hydroxy-l-methyl-4-(4-methylphenyl)-3-piperidyl 4-methylphenyl ketone, as a potential cocaine antagonist through 3D-database pharmacophore searching. Molecular modeling, structure-activity relationships, and behavioral pharmacological studies
30. Electrostatic potential molecular surfaces